S
Sorrento Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 2006 · IPO 2010 Unicorn
Global footprint
Where Sorrento Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$128M patent portfolio · 94 active families
Where Sorrento Therapeutics concentrates vs peers
Each axis is a top-10 topic across Sorrento Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Sorrento Therapeutics's 7 investments and acquisitions.
Every disclosed deal where Sorrento Therapeutics appeared as a backer or acquirer, 2015–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
7 deals across Sorrento Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Sorrento Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Sorrento Therapeutics
An AI-synthesized read of the highest-engagement posts about Sorrento Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sorrento Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.